Abstract
Over the past decade, much effort has been made to understand how cancers metastasize. In deciphering the metastatic process, a vast amount of work has focused on the role of the epithelial to mesenchymal transition (EMT), which, in experimental models, confers tumor cells with invasive and metastatic abilities, resistance to therapies, as well as cancer stem cell phenotype—properties that have a major impact on cancer prognosis. Searching “EMT and cancer” in PubMed retrieves thousands of original research articles, yet, we haven’t answered the most basic question in the field: has EMT any relevance in human tumors?
Similar content being viewed by others
References
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117(7), 927–939.
Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871–890.
Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.
Xue, C., Plieth, D., Venkov, C., Xu, C., & Neilson, E. G. (2003). The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Research, 63(12), 3386–3394.
Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., et al. (2008). Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Research, 68(3), 937–945.
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., et al. (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131(3), 830–840.
Prall, F. (2007). Tumour budding in colorectal carcinoma. Histopathology, 50(1), 151–162.
Ueno, H., Mochizuki, H., Hashiguchi, Y., Shimazaki, H., Aida, S., Hase, K., et al. (2004). Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology, 127(2), 385–394.
Zlobec, I., & Lugli, A. (2010). Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget, 1(7), 651–661.
Ansieau, S., Bastid, J., Doreau, A., Morel, A. P., Bouchet, B. P., Thomas, C., et al. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 14(1), 79–89.
Prall, F., & Ostwald, C. (2007). High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. Human Pathology, 38(11), 1696–1702.
Wang, C., Huang, H., Huang, Z., Wang, A., Chen, X., Huang, L., et al. (2011). Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. Journal of Oral Pathology & Medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research, 11(4).
Raimondi, C., Gradilone, A., Naso, G., Vincenzi, B., Petracca, A., Nicolazzo, C., et al. (2011). Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Research and Treatment. doi:10.1007/s10549-011-1373-x.
Rees, J. R., Onwuegbusi, B. A., Save, V. E., Alderson, D., & Fitzgerald, R. C. (2006). In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Research, 66(19), 9583–9590.
Montserrat, N., Mozos, A., Llobet, D., Dolcet, X., Pons, C., de Herreros, A. G., et al. (2011). Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma. Human Pathology. doi:10.1016/j.humpath.2011.06.021.
van Deurzen, C. H., Lee, A. H., Gill, M. S., Menke-Pluijmers, M. B., Jager, A., Ellis, I. O., et al. (2011). Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? The Journal of Pathology. doi:10.1002/path.2872.
Halachmi, S., DeMarzo, A. M., Chow, N. H., Halachmi, N., Smith, A. E., Linn, J. F., et al. (2000). Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. European Urology, 37(3), 350–357.
Zhuang, Z., Lininger, R. A., Man, Y. G., Albuquerque, A., Merino, M. J., & Tavassoli, F. A. (1997). Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Modern Pathology, 10(4), 354–362.
Teixeira, M. R., Qvist, H., Bohler, P. J., Pandis, N., & Heim, S. (1998). Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin. Genes, Chromosomes & Cancer, 22(2), 145–151.
Fujii, H., Yoshida, M., Gong, Z. X., Matsumoto, T., Hamano, Y., Fukunaga, M., et al. (2000). Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Research, 60(1), 114–120.
Tarin, D., Thompson, E. W., & Newgreen, D. F. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65(14), 5996–6000. discussion 6000-5991.
Sivertsen, S., Hadar, R., Elloul, S., Vintman, L., Bedrossian, C., Reich, R., et al. (2006). Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer, 54(3), 309–317.
Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Hofler, H., & Becker, K. F. (2008). The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. British Journal of Cancer, 98(2), 489–495.
Cates, J. M., Byrd, R. H., Fohn, L. E., Tatsas, A. D., Washington, M. K., & Black, C. C. (2009). Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas, 38(1), e1–6. doi:10.1097/MPA.0b013e3181878b7f.
Scheel, C., Eaton, E. N., Li, S. H., Chaffer, C. L., Reinhardt, F., Kah, K. J., et al. (2011). Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 145(6), 926–940.
Thiery, J. P., & Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology, 7(2), 131–142.
Olmeda, D., Jorda, M., Peinado, H., Fabra, A., & Cano, A. (2007). Snail silencing effectively suppresses tumour growth and invasiveness. [Research Support, Non-U.S. Gov't]. Oncogene, 26(13), 1862–1874.
Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006). Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Research, 66(23), 11271–11278.
Bonnomet, A., Syne, L., Brysse, A., Feyereisen, E., Thompson, E. W., Noel, A., et al. (2011). A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. doi:10.1038/onc.2011.540.
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., et al. (2005). Tumour biology: Senescence in premalignant tumours. Nature, 436(7051), 642.
Eng, C., Leone, G., Orloff, M. S., & Ostrowski, M. C. (2009). Genomic alterations in tumor stroma. Cancer Research, 69(17), 6759–6764.
Gjorevski, N., Boghaert, E., & Nelson, C. M. (2011). Regulation of epithelial-mesenchymal transition by transmission of mechanical stress through epithelial tissues. Cancer Microenvironment: official journal of the International Cancer Microenvironment Society. doi:10.1007/s12307-011-0076-5.
Yang, M. H., Wu, M. Z., Chiou, S. H., Chen, P. M., Chang, S. Y., Liu, C. J., et al. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. [Research Support, Non-U.S. Gov't]. Nature Cell Biology, 10(3), 295–305. doi:10.1038/ncb1691.
Koo, V., El Mekabaty, A., Hamilton, P., Maxwell, P., Sharaf, O., Diamond, J., et al. (2010). Novel in vitro assays for the characterization of EMT in tumourigenesis. Cellular Oncology, 32(1–2).
Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., et al. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. Journal of Biological Chemistry, 277(42), 39209–39216.
Gradilone, A., Raimondi, C., Nicolazzo, C., Petracca, A., Gandini, O., Vincenzi, B., et al. (2011). Circulating tumor cells lacking cytokeratin in breast cancer: The importance of being mesenchymal. Journal of Cellular and Molecular Medicine. doi:10.1111/j.1582-4934.2011.01285.x.
Greenburg, G., & Hay, E. D. (1982). Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. The Journal of Cell Biology, 95(1), 333–339.
Stoker, M., & Perryman, M. (1985). An epithelial scatter factor released by embryo fibroblasts. Journal of Cell Science, 77, 209–223.
Stoker, M., Gherardi, E., Perryman, M., & Gray, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 327(6119), 239–242.
Maestro, R., Dei Tos, A. P., Hamamori, Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., et al. (1999). Twist is a potential oncogene that inhibits apoptosis. Genes & Development, 13(17), 2207–2217.
Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., et al. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology, 2(2), 76–83.
Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., et al. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biology, 2(2), 84–89.
Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer, 2(6), 442–454.
Inoue, A., Seidel, M. G., Wu, W., Kamizono, S., Ferrando, A. A., Bronson, R. T., et al. (2002). Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell, 2(4), 279–288.
Kajita, M., McClinic, K. N., & Wade, P. A. (2004). Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Molecular and Cellular Biology, 24(17), 7559–7566.
Wu, W. S., Heinrichs, S., Xu, D., Garrison, S. P., Zambetti, G. P., Adams, J. M., et al. (2005). Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell, 123(4), 641–653.
Knutson, K. L., Lu, H., Stone, B., Reiman, J. M., Behrens, M. D., Prosperi, C. M., et al. (2006). Immunoediting of cancers may lead to epithelial to mesenchymal transition. Journal of Immunology, 177(3), 1526–1533.
Peinado, H., Olmeda, D., & Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nature Reviews. Cancer, 7(6), 415–428.
Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715.
Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008). Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3(8), e2888. doi:10.1371/journal.pone.0002888.
Chang, C. J., Chao, C. H., Xia, W., Yang, J. Y., Xiong, Y., Li, C. W., et al. (2011). p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology, 13(3), 317–323.
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., et al. (2009). Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Research, 69(7), 2887–2895.
Acknowledgments
I would like to acknowledge scientific discussions and helpful comments from Dr. C. Thomas, as well as critical reading of the manuscript by A. Doreau-Bastid and Dr. G. Alberici.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bastid, J. EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev 31, 277–283 (2012). https://doi.org/10.1007/s10555-011-9344-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-011-9344-6